Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Bangham (London, United Kingdom), K. Myall (London, United Kingdom). Investigating microbial communities in interstitial lung disease by standard culture of bronchioalveolar lavage samples. 2960

Member's Comments

No comment yet.

Related content which might interest you: Comparison of cellular composition of induced sputum, bronchial washing and bronchoalveolar lavage fluid in some interstitial lung diseases Source: Eur Respir J 2002; 20: Suppl. 38, 313s Year: 2002 Influence of systemic steroid treatment on bronchoalveolar (BAL) cytological composition and cell cycle in selected interstitial lung diseases Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Evaluation of bacterial colonisation by quantitative culturing method in sputum and bronchoalveolar lavage fluid of patients with bronchiectasis in the stable period Source: Annual Congress 2004 - Bronchiectasis Year: 2004 What does bronchoalveolar lavage add to cryobiopsy in interstitial lung disease? Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018 The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease Source: Eur Respir Rev 2010 19: 237-241 Year: 2010 The role of bronchoalveolar lavage cellular analysis in the diagnosis of interstitial lung diseases Source: Eur Respir Mon; 2009: 46: 36–46 Year: 2009 Interstitial lung disease profiling by mean of broncho-alveolar lavage Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 Characterization of macrophages from bronchoalveolar lavage of COPD patients with and without bacterial colonization Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018 The importance of cytological analysis of bronchoalveolar lavage in tuberculous lung disease Source: Eur Respir J 2007; 30: Suppl. 51, 662s Year: 2007 Characterization of myofibroblasts cultured from small volumes of diagnostic bronchoalveolar lavage fluid samples Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls Source: International Congress 2014 – ILDs 4 Year: 2014 Induced sputum in nonsarcoid interstitial lung diseases; comparison with bronchial wash and BAL Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 Induced sputum in interstitial lung diseases; comparison with bronchial wash and BAL Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 Immune alveolitis profile in bronchoalveolar lavage of infiltrative lung diseases: not just counting matters. Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Profile of antimicrobial peptides in the bronchoalveolar lavage of patients with interstitial lung diseases Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis Year: 2021 Concordance analysis of cells present in bronchoalveolar lavage in patients with interstitial lung diseases by type of readings and pulmonary location Source: International Congress 2017 – ILDs: clinical problems Year: 2017 High levels of pepsin A in bronchoalveolar lavage fluid of patients with exacerbation of interstitial lung diseases and no evidence of infection Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Source: Eur Respir J 2011; 38: 761-769 Year: 2011 Tumour markers in bronchoalveolar lavage and its diagnostic contribution in lung cancer not visible through regular fibrobronchoscopy Source: Eur Respir J 2002; 20: Suppl. 38, 276s Year: 2002 Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases? Source: International Congress 2015 – New insights into IIPs Year: 2015